First Bancorp’s Bristol-Myers Squibb BMY Stock Holding History

First Bancorp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$418K	Hold	7,257	–	–	0.17%	93
2026 Q1	$440K	Sell	7,257 -25	-0.3%	-$1.46K	0.22%	85
2025 Q4	$393K	Buy	7,282 +1,166	+19%	+$56.1K	0.21%	91
2025 Q3	$276K	Sell	6,116 -105	-2%	-$4.9K	0.15%	113
2025 Q2	$288K	Sell	6,221 -64	-1%	-$3.14K	0.17%	106
2025 Q1	$383K	Hold	6,285	–	–	0.25%	88
2024 Q4	$355K	Sell	6,285 -138	-2%	-$7.71K	0.24%	94
2024 Q3	$332K	Hold	6,423	–	–	0.23%	94
2024 Q2	$267K	Buy	6,423 +500	+8%	+$22.4K	0.2%	100
2024 Q1	$321K	Buy	5,923 +805	+16%	+$41K	0.24%	88
2023 Q4	$263K	Hold	5,118	–	–	0.21%	98
2023 Q3	$297K	Buy	5,118 +134	+3%	+$8.21K	0.26%	83
2023 Q2	$319K	Sell	4,984 -98	-2%	-$6.57K	0.26%	82
2023 Q1	$352K	Sell	5,082 -200	-4%	-$14.1K	0.3%	74
2022 Q4	$380K	Sell	5,282 -380	-7%	-$28.7K	0.32%	69
2022 Q3	$403K	Sell	5,662 -295	-5%	-$21.4K	0.37%	63
2022 Q2	$459K	Sell	5,957 -65	-1%	-$4.95K	0.43%	54
2022 Q1	$440K	Sell	6,022 -60	-1%	-$4.03K	0.4%	52
2021 Q4	$379K	Hold	6,082	–	–	0.33%	59
2021 Q3	$360K	Buy	+6,082	New	+$401K	0.34%	61
2021 Q1	$371K	Buy	+5,889	New	+$366K	0.37%	59

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

First Bancorp's BMY Position: Q2 2026 in Review

First Bancorp held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 7,257 shares worth $418K. The position accounts for 0.17% of the portfolio, ranked #93.

First Bancorp first reported a position in BMY in Q1 2021 and has held it in 21 quarters since. The position peaked at $459K in Q2 2022. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

First Bancorp held 7,257 shares of Bristol-Myers Squibb worth $418K as of Q2 2026.
First Bancorp left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.17% of First Bancorp's portfolio in Q2 2026, its #93 holding.
First Bancorp first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 21 quarters since.
First Bancorp's Bristol-Myers Squibb position peaked at $459K in Q2 2022.
2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on First Bancorp's 13F filing for Q2 2026, filed 11 Aug 2026.